Hypervolemia: Difference between revisions
Line 14: | Line 14: | ||
==Causes== | ==Causes== | ||
===Drugs=== | ===Drugs=== | ||
*[[ | *[[Caspofungin acetate]] | ||
*[[Meropenem]] | *[[Meropenem]] | ||
*[[Teduglutide]] | |||
==Related chapters== | ==Related chapters== |
Latest revision as of 21:00, 18 February 2015
Template:DiseaseDisorder infobox
WikiDoc Resources for Hypervolemia |
Articles |
---|
Most recent articles on Hypervolemia Most cited articles on Hypervolemia |
Media |
Powerpoint slides on Hypervolemia |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Hypervolemia at Clinical Trials.gov Clinical Trials on Hypervolemia at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Hypervolemia
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Hypervolemia Discussion groups on Hypervolemia Patient Handouts on Hypervolemia Directions to Hospitals Treating Hypervolemia Risk calculators and risk factors for Hypervolemia
|
Healthcare Provider Resources |
Causes & Risk Factors for Hypervolemia |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hypervolemia (or "Fluid overload") is the medical condition where there is too much fluid in the blood. The fluid can either be intravascular or extravascular and result in edema.
The opposite condition is Hypovolemia (too little fluid volume in the blood).
Causes
Drugs
Related chapters
- volume status
- edema
- anasarca (swelling of skin)
- ascites (excess fluid in the peritoneal cavity)
- pleural effusion (excess fluid in the pleural cavity)
Resources
Template:Endocrine, nutritional and metabolic pathology de:Hypervolämie